冠状动脉粥样硬化所致的血管狭窄及粥样硬化斑块破裂所诱发的急性血栓形成是冠心病发病的两个主要的病理生理因素,血小板是惟一参与这两个病理生理过程的细胞,抗血小板治疗是冠心病治疗中不可缺少的重要组成部分。近年来,随着循证医学的不断发展,越来越多的有关抗血小板治疗的 Coronary atherosclerosis caused by vascular stenosis and atherosclerotic plaque rupture induced acute thrombosis is the incidence of coronary heart disease two major pathophysiological factors, platelets are the only cells involved in these two pathophysiological processes, anti-anti Platelet therapy is an essential part of coronary heart disease treatment. In recent years, with the continuous development of evidence-based medicine, more and more anti-platelet therapy